Insider sale at Marex Group (MRX): officer sells 16,666 shares under 10b5-1 plan
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Marex Group plc officer Paolo Tonucci reported selling 16,666 Ordinary Shares of the company in open-market transactions. The sales took place on June 15, 2026 at weighted average prices around the low $60s, with individual trade prices ranging from $60.945 to $63.075.
The filing notes these trades were executed under a pre-arranged Rule 10b5-1 trading plan entered into on October 22, 2025, indicating they were scheduled in advance. Tonucci’s reported holdings include 220,746 ordinary shares underlying deferred bonus plan awards that convert into one ordinary share each upon vesting and settlement.
Positive
- None.
Negative
- None.
Insights
Pre-planned insider sale of 16,666 shares, routine in scale.
Marex Group officer Paolo Tonucci sold 16,666 Ordinary Shares on June 15, 2026 via three open-market transactions. Reported weighted average prices ranged from about $61.74 to $63.00, with detailed trade ranges between $60.945 and $63.075.
The trades were executed under a Rule 10b5-1 plan adopted on October 22, 2025, meaning the sales were pre-scheduled rather than opportunistic. The filing also notes 220,746 shares tied to deferred bonus plan awards, so equity exposure remains meaningful. Overall, this looks like routine, planned liquidity rather than a thesis-changing move.
Insider Trade Summary 10b5-1
Net Seller: 16,666 shares ($1,040,849)
Net Sell
3 txns
Insider
Tonucci Paolo
Role
See Remarks
Sold
16,666 shs ($1.04M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Ordinary Shares | 1,658 | $61.7412 | $102K |
| Sale | Ordinary Shares | 14,199 | $62.5055 | $888K |
| Sale | Ordinary Shares | 809 | $62.9994 | $51K |
Holdings After Transaction:
Ordinary Shares — 1,313,951 shares (Direct, null)
Footnotes (1)
- The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into by the Reporting Person on October 22, 2025. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $60.945 to $61.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $61.965 to $62.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported in Column 4 is a weighted average price. These shares were sold in transactions at prices ranging from $62.945 to $63.075, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards previously granted to the Reporting Person. Each award represents a contingent right to receive one (1) ordinary share of the Issuer upon vesting and settlement of the applicable award.
Key Figures
Shares sold: 16,666 shares
Sale price (transaction 1): $62.9994 per share
Sale price (transaction 2): $62.5055 per share
+5 more
8 metrics
Shares sold
16,666 shares
Total Ordinary Shares sold on June 15, 2026
Sale price (transaction 1)
$62.9994 per share
Weighted average price for 809 shares sold
Sale price (transaction 2)
$62.5055 per share
Weighted average price for 14,199 shares sold
Sale price (transaction 3)
$61.7412 per share
Weighted average price for 1,658 shares sold
Trade price range (low)
$60.945 per share
Lowest individual trade price disclosed in footnotes
Trade price range (high)
$63.075 per share
Highest individual trade price disclosed in footnotes
Deferred bonus plan shares
220,746 shares
Ordinary shares underlying deferred bonus plan awards
10b5-1 plan date
October 22, 2025
Date Rule 10b5-1 trading plan was entered into
Key Terms
Rule 10b5-1 plan, weighted average price, deferred bonus plan awards, contingent right, +1 more
5 terms
Rule 10b5-1 plan regulatory
"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 plan entered into..."
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
weighted average price financial
"The price reported in Column 4 is a weighted average price. These shares were sold..."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
deferred bonus plan awards financial
"The number of ordinary shares reported herein includes 220,746 shares underlying deferred bonus plan awards..."
Deferred bonus plan awards are payments promised to employees or executives that are earned now but paid out later, often only if certain performance goals are met or the employee remains with the company. For investors, they matter because they influence management’s incentives and company expenses over time—like a delayed paycheck that encourages someone to stay and meet targets—and can affect future cash needs, reported compensation costs, and potential share dilution.
contingent right financial
"Each award represents a contingent right to receive one (1) ordinary share of the Issuer..."
open-market sale financial
"transaction_action": "open-market sale","transaction_code_description": "Sale in open market or private transaction""
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
FAQ
What type of Marex Group (MRX) security did Paolo Tonucci sell?
All reported transactions involve Ordinary Shares of Marex Group plc as non-derivative securities. There are no option exercises or derivative conversions in this filing; each transaction is an open-market sale of existing Ordinary Shares held directly.
Is this Marex Group (MRX) insider sale large relative to the position?
The filing reports 16,666 shares sold, while also indicating a substantial number of shares tied to deferred bonus awards. It shows ongoing equity exposure, and, combined with the pre-planned Rule 10b5-1 status, suggests a routine liquidity event rather than an outsized position change.